Get started
Award

R37CA248289

Funded outputs count: 28
Funder award ID: R37CA248289
OpenAlex ID: G1663100945
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma
2026 · Paul B. Romesser, Aron Bercz, et al. · Nature Communications · 2
Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservation
2026 · W. Zambare, R. Ravella, et al. · Clinical and Translational Radiation Oncology
PDF
Access to and Delivery of High-Quality Cancer Care
2025 · Norman J. Galbraith, Y. Nancy You, et al. · JAMA Surgery
Rethinking Local Therapy for Rectal Cancer in the Era of Precision Oncology—When Less Is More
2025 · Aron Bercz, Philip S. Bauer, et al. · JAMA Surgery
Assessment of morbidity and predictors of wound complications following perineal wound closure after radical anorectal oncologic resection: retrospective cohort study
2025 · Aron Bercz, Janet Alvarez, et al. · BJS Open · 4
PDF
Near Complete Response: An Opportunity for Organ Preservation in Rectal Cancer
2025 · Wini Zambare, J. Joshua Smith · Annals of Surgical Oncology · 2
PDF
Lessons from FOWARC: moving towards the more precise use of radiation therapy in the era of total neoadjuvant therapy
2025 · Aron Bercz, Wini Zambare, et al. · AME Clinical Trials Review
Utilizing Patient Input in Rectal Cancer Trial Design
2025 · Janet Alvarez, Wini Zambare, et al. · JNCI Journal of the National Cancer Institute · 4
Integrating Tumor and Organoid DNA Methylation Profiles Reveals Robust Predictors of Chemotherapy Response in Rectal Cancer
2025 · David Lukacsovich, Wini Zambare, et al. · medRxiv
PDF
Appraising a CREATEive Surgeon-Scientist Initiative: Impact and Future Directions
2025 · Christopher J. Neylan, Aron Bercz, et al. · Diseases of the Colon & Rectum
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection
2025 · Wei Zhang, Chao Wu, et al. · Translational Oncology · 8
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait
2024 · Roni Y. Rosen, Aron P. Bercz, et al. · Diseases of the Colon & Rectum · 14
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
2024 · A. Bercz, B.K. Park, et al. · Annals of Oncology · 32
PDF
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
2024 · Janet A. Alvarez, Qian Shi, et al. · BMC Cancer · 49
PDF
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers
2024 · Daniel P. Nussbaum, Colin A. Martz, et al. · npj Precision Oncology · 8
Watch & wait - Post neoadjuvant imaging for rectal cancer
2024 · Maria El Homsi, Aron Bercz, et al. · Clinical Imaging · 2
Future direction of total neoadjuvant therapy for locally advanced rectal cancer
2024 · Yoshinori Kagawa, J. Joshua Smith, et al. · Nature Reviews Gastroenterology & Hepatology · 83
PDF
Discovery of Oncogenic Mediator Genes in Rectal Cancer Chemotherapy Response using Gene Expression Data from Matched Tumor and Patient-Derived Organoid
2024 · Hanchen Huang, Chao Wu, et al. · medRxiv · 2
PDF
Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management
2023 · Yael Feferman, Roni Y. Rosen, et al. · Diseases of the Colon & Rectum · 1
PDF
Data from Colorectal Cancer Develops Inherent Radiosensitivity That Can Be Predicted Using Patient-Derived Organoids
2023 · Kuo-Shun Hsu, Mohammad Adileh, et al.
An immunocompetent rectal cancer model to study radiation therapy
2022 · Jin K. Kim, Chao Wu, et al. · Cell Reports Methods · 7
PDF
Achieving a Cure Without Total Mesorectal Excision in Rectal Adenocarcinoma
2022 · William A. Hall, J. Joshua Smith · Journal of Clinical Oncology · 16
A methylation-based prognostic signature in stage II colorectal patients: Considerations for clinical adoption
2022 · Paul B Romesser, Francisco Sanchez-Vega, et al. · JNCI Journal of the National Cancer Institute · 1
PDF
Sensitisation of cancer cells to radiotherapy by serine and glycine starvation
2022 · Mattia Falcone, Alejandro Huerta Uribe, et al. · British Journal of Cancer · 62
PDF
Colorectal Cancer Develops Inherent Radiosensitivity That Can Be Predicted Using Patient-Derived Organoids
2022 · Kuo-Shun Hsu, Mohammad Adileh, et al. · Cancer Research · 44
PDF
Year
Topic